Evaxion A (EVAX) Cash & Equivalents (2019 - 2026)
Evaxion A (EVAX) posted Cash & Equivalents of $18.4 million for Q1 2026, down 20.63% on a QoQ basis from $23.2 million in Q4 2025, and up 3.35% year-over-year from $17.8 million in Q1 2025.
Evaxion A (EVAX) Cash & Equivalents (2019 - 2026) Analysis & Trends
Evaxion A's Cash & Equivalents history runs 8 years deep, the most recent figure standing at $18.4 million for Q1 2026.
- Quarterly Cash & Equivalents rose 3.35% year-over-year to $18.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.4 million (up 3.35% YoY) and the FY2025 annual result came in at $23.2 million, up 290.36% from the prior year.
- Cash & Equivalents was $18.4 million for Q1 2026 at Evaxion A, down from $23.2 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $31.4 million in Q1 2022 and bottomed at $11731.0 in Q1 2024.
- A 5-year average of $13.3 million and a median of $11.9 million in 2022 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2024 — Cash & Equivalents sank 99.89% — and 2025, when it soared 152001.27%.
- Evaxion A's Cash & Equivalents stood at $13.2 million in 2022, then tumbled by 57.65% to $5.6 million in 2023, then gained by 6.61% to $6.0 million in 2024, then soared by 290.36% to $23.2 million in 2025, then slipped by 20.63% to $18.4 million in 2026.
- Business Quant data shows EVAX's Cash & Equivalents at $18.4 million in Q1 2026, $23.2 million in Q4 2025, and $10.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 82.45 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 2.83 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 5.49 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 440.94 Mn |
| 10 | Evaxion A | 1.23 Bn | 1.23 Bn | - | 18.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.44 Mn |
| Dec 31, 2025 | 23.23 Mn |
| Sep 30, 2025 | 10.57 Mn |
| Jun 30, 2025 | 14.75 Mn |
| Mar 31, 2025 | 17.84 Mn |
| Dec 31, 2024 | 5.95 Mn |
| Jun 30, 2024 | 7.99 Mn |
| Mar 31, 2024 | 11,731.00 |
| Dec 31, 2023 | 5.58 Mn |
| Sep 30, 2023 | 2.61 Mn |
| Jun 30, 2023 | 7.12 Mn |
| Mar 31, 2023 | 10.24 Mn |
| Dec 31, 2022 | 13.18 Mn |
| Sep 30, 2022 | 17.85 Mn |
| Jun 30, 2022 | 25.25 Mn |
| Mar 31, 2022 | 31.41 Mn |
| Dec 31, 2021 | 32.17 Mn |
| Sep 30, 2021 | 11.94 Mn |
| Jun 30, 2021 | 18.80 Mn |
| Mar 31, 2021 | 26.96 Mn |